Disposition of Flavonoids via Enteric Recycling: Enzyme-Transporter Coupling Affects Metabolism of Biochanin A and Formononetin and Excretion of Their Phase II Conjugates
Open Access
- 1 September 2004
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 310 (3) , 1103-1113
- https://doi.org/10.1124/jpet.104.068403
Abstract
The purpose of this study was to continue our effort to determine how enzyme-transporter coupling affect disposition of flavonoids. The rat intestinal perfusion and Caco-2 cell models were used together with relevant microsomes. In perfusion model, isoflavone (i.e., formononetin and biochanin A) absorption and subsequent excretion of its metabolites were always site-dependent. Maximal amounts of intestinal and biliary conjugates excreted per 30 min were 31 and 51 nmol for formononetin, more than that for pure biochanin A (12 and 20 nmol). When a standardized red clover extract (biochanin A/formononetin = 10:7) was used, the results indicated that more metabolites of biochanin A than formononetin were found in the perfusate (36.9 versus 22.8 nmol) and bile (78 versus 51 nmol). In metabolism studies, rat intestinal and liver microsomes always glucuronidated biochanin A faster (p < 0.05) than formononetin, whereas intestinal microsomes glucuronidated both isoflavones faster (p < 0.05) than liver microsomes. However, rapid metabolism in the microsomes did not translate into more efficient excretion in either the rat perfusion model as shown previously or in the Caco-2 model. In the Caco-2 model, both isoflavones were rapidly absorbed, efficiently conjugated, and the conjugates excreted apically and basolaterally. More formononetin conjugates were excreted than biochanin A when used alone, but much more biochanin A conjugates were found when using the isoflavone mixture. In conclusion, efficiency of enzyme-transporter coupling controls the amounts of metabolites excreted by the intestine and liver and determines the relative contribution of enteric and enterohepatic recycling to the in vivo disposition of isoflavones.Keywords
This publication has 34 references indexed in Scilit:
- Metabolism of Flavonoids via Enteric Recycling: Mechanistic Studies of Disposition of Apigenin in the Caco-2 Cell Culture ModelThe Journal of Pharmacology and Experimental Therapeutics, 2003
- IDENTIFICATION OF CYP1A2 AS THE MAIN ISOFORM FOR THE PHASE I HYDROXYLATED METABOLISM OF GENISTEIN AND A PRODRUG CONVERTING ENZYME OF METHYLATED ISOFLAVONESDrug Metabolism and Disposition, 2003
- Metabolism of Flavonoids via Enteric Recycling: Role of Intestinal DispositionThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Absorption of quercetin-3-glucoside and quercetin-4′-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporterPublished by Elsevier ,2003
- Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy menThe American Journal of Clinical Nutrition, 2002
- Dietary agents in cancer prevention: flavonoids and isoflavonoidsPharmacology & Therapeutics, 2001
- Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in womenClimacteric, 1999
- Determination of Absorption Characteristics of AG337, a Novel Thymidylate Synthase Inhibitor, Using a Perfused Rat Intestinal ModelJournal of Pharmaceutical Sciences, 1998
- Mechanism and Kinetics of Transcellular Transport of a New β-Lactam Antibiotic Loracarbef Across an Intestinal Epithelial Membrane Model System (Caco-2)Pharmaceutical Research, 1994
- The Caco-2 Cell Monolayers as an Intestinal Metabolism Model: Metabolism of Dipeptide Phe-ProJournal of Drug Targeting, 1994